A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Value-based care can help give providers flexibility to innovate care and holds them accountable for clinical outcomes and cost of treating an entire population.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Premier is helping to bridge the gap among patients, providers and suppliers and optimize the care delivery system.
Using data and technology to drive decisions around the right supplies, services and equipment for optimal care delivery, safety, outcomes and total cost.
Premier is supporting the CoC with dedicated staff experts, technology-driven supply chain tools, AI-backed surveillance solutions and by advocating for necessary legislative reform.
PINC AI™ data helps fuel research with insights from more than 1,188 sites to provide data for evidence- and population-based analyses.
Health Affairs |
Premier's Michael J. Alkire and Soumi Saha detail five policy areas in health care that we believe should be tackled in 2023.
University Hospitals is collaborating with PAS to advance research, RWE generation and explore the development of new solutions, interventions and other healthcare initiatives.